drugset / Trial / NCT02135770

Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis

NCT02135770

Phase 3 Completed 115 enrolled Indonesia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Sepsis is a clinical syndrome which infection trigger systemic inflammatory response. Uncontrolled inflammatory process leads to multiple organ dysfunction and cause early mortality in severe sepsis. Unfractionated heparin is an anticoagulant that widely used either for DVT prophylaxis or treatment of disseminated intravascular coagulation. Heparin also have an anti-inflammatory effect through downregulates nuclear factor kappa B and tumor necrosis factor alpha. Aim of this study is to determine effects of low dose unfractionated heparin treatment on inflammation in severe sepsis patient.

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 10 iu/kg